Recent clinical advances using RAS-targeted small-molecule inhibitors, including daraxonrasib, a RAS(ON) multi-selective, noncovalent, tri-complex inhibitor, has shown promising responses but are limited in durability for pancreatic ductal adenocarcinoma (PDAC). Preclinical studies indicate that RAS inhibition ca...
Zi-Rui Zhu, Benjamin C. Barrett, Aadi Bhattacharya et al.· Cancer Research· 0 citations
Background Alopecia areata (AA) causes non-scarring hair loss and substantial psychosocial burden, yet its trends, comorbidities, and future burden in East Asia remain underexplored. Methods Global Burden of Disease(GBD) Study 2023 data from 1990–2023 were analyzed for the world, China, Japan, and South Korea. Age-stan...
Yue Pan, Xiang-Hui Li, Gao Wei et al.· Clinical, Cosmetic and Inves...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.